Quest Diagnostics, Inc. (DGX) Tops Q3 EPS by 7c; Guides FY11 EPS Above Views
Tweet
Share
E-mailGet Alerts DGX Hot Sheet
Price: $193.67 +0.26%
Revenue Growth %: +7.6%
Financial Fact:
Net income: 1.34
Today's EPS Names:
CRMT, REPL, HURC, More
Revenue Growth %: +7.6%
Financial Fact:
Net income: 1.34
Today's EPS Names:
CRMT, REPL, HURC, More
Join SI Premium – FREE
Quest Diagnostics, Inc. (NYSE: DGX) reported Q3 EPS of $1.18, $0.07 better than the analyst estimate of $1.11. Revenue for the quarter came in at $1.9 billion versus the consensus estimate of $1.89 billion.
Quest Diagnostics, Inc. sees FY2011 EPS of $4.30-$4.35, versus the consensus of $4.21. Sees revenues growing 1.5%, unchanged from previous guidance
Quest Diagnostics, Inc. sees FY2011 EPS of $4.30-$4.35, versus the consensus of $4.21. Sees revenues growing 1.5%, unchanged from previous guidance
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
- Five Below (FIVE) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY27 Guidance
- Tilly's, Inc. (TLYS) Tops Q1 EPS by 44c ; offer guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
